ESCAPE THERAPEUTICS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ESCAPE THERAPEUTICS, INC..The latest application filed is for "tyrosine inhibitors with immunosuppressive activity in human neonatal keratinocyte progenitors".

Company Profile

3.18.20

ESCAPE THERAPEUTICS, INC. - Turlock CA US
Escape Therapeutics, Inc. - San Jose CA US
Escape Therapeutics, Inc. - N/A N/A N/A
ESCAPE THERAPEUTICS, INC. - East Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tyrosine Inhibitors with Immunosuppressive Activity in Human Neonatal Keratinocyte Progenitors App 20220088116 - HANTASH; Basil M.	2022-03-24
Enhanced Differentiation Of Mesenchymal Stem Cells App 20210032599 - HANTASH; Basil M.	2021-02-04
Mesenchymal Stem Cells With Enhanced Immunosuppressive Capability App 20200155610 - HANTASH; Basil M.	2020-05-21
Mesenchymal stem cells with enhanced immunosuppressive capability Grant 10,576,105 - Hantash	2020-03-03
Enhanced Differentiation Of Mesenchymal Stem Cells App 20180327718 - HANTASH; Basil M.	2018-11-15
Decapeptide-12 Modulation of Sirtuin Gene Expression in Epidermal Keratinocyte Progenitors App 20180296456 - Hantash; Basil M. ; et al.	2018-10-18
Enhanced differentiation of mesenchymal stem cells Grant 10,053,670 - Hantash August 21, 2	2018-08-21
Hla G-modified Cells And Methods App 20170292952 - HANTASH; Basil M.	2017-10-12
HLA G-modified cells and methods Grant 9,714,280 - Hantash July 25, 2	2017-07-25
Mesenchymal Stem Cells With Enhanced Immunosuppressive Capability App 20170065639 - HANTASH; Basil M.	2017-03-09
Peptide tyrosinase activators Grant 9,567,368 - Hantash , et al. February 14, 2	2017-02-14
System for evaluating skin treatment Grant 9,554,746 - Hantash January 31, 2	2017-01-31
Compositions comprising mesenchymal stem cell-derived fibroblasts Grant 9,382,514 - Hantash July 5, 2	2016-07-05
Endogenous Expression Of Hla-g And/or Hla-e By Mesenchymal Cells App 20160152953 - HANTASH; Basil M.	2016-06-02
Differentiation of mesenchymal stem cells into fibroblasts Grant 9,347,045 - Hantash May 24, 2	2016-05-24
Enhanced Differentiation Of Mesenchymal Stem Cells App 20160130556 - HANTASH; Basil M.	2016-05-12
Peptide tyrosinase inhibitors and uses thereof Grant 9,320,698 - Hantash , et al. April 26, 2	2016-04-26
Hybrid Hydrogel Scaffold Compositions And Methods Of Use App 20150320865 - HANTASH; Basil M. ; et al.	2015-11-12
Hla G-modified Cells And Methods App 20150158927 - HANTASH; Basil M.	2015-06-11
Peptide Tyrosinase Activators App 20150152139 - Hantash; Basil M. ; et al.	2015-06-04
Hybrid hydrogel scaffold compositions and methods of use Grant 8,911,723 - Hantash , et al. December 16, 2	2014-12-16
Differentiation of mesenchymal stem cells into fibroblasts, compositions comprising mesenchymal stem cell-derived fibroblasts, and methods of using the same Grant 8,822,215 - Hantash September 2, 2	2014-09-02
Endogenous Expression of HLA-G and/or HLA-E by Mesenchymal Cells App 20140193382 - HANTASH; Basil M.	2014-07-10
Endogenous expression of HLA-G and/or HLA-E by mesenchymal cells Grant 8,647,871 - Hantash February 11, 2	2014-02-11
Differentiation Of Mesenchymal Stem Cells Into Fibroblasts, Compositions Comprising Mesenchymal Stem Cell-derived Fibroblasts, And Methods Of Using The Same App 20130121973 - HANTASH; Basil M.	2013-05-16
Differentiation Of Mesenchymal Stem Cells Into Fibroblasts, Compositions Comprising Mesenchymal Stem Cell-derived Fibroblasts, And Methods Of Using The Same App 20130122521 - HANTASH; Basil M.	2013-05-16
Hybrid Hydrogel Scaffold Compositions And Methods Of Use App 20130115196 - HANTASH; Basil M. ; et al.	2013-05-09
Differentiation Of Mesenchymal Stem Cells Into Fibroblasts, Compositions Comprising Mesenchymal Stem Cell-derived Fibroblasts, And Methods Of Using The Same App 20110081326 - HANTASH; Basil M.	2011-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.